Treatment with systemic intravenous olvimulogene nanivacirepvec (Olvi-Vec) led to promising preliminary results in patients ...

AI in oncology nursing remains in its early stages, but it’s already reshaping health care. This moment was evident at the 2025 American Society of Hematology Annual Meeting and Exposition, which ...

Recent regulatory actions from the FDA, including new drug application (NDA) acceptances and labeling updates, introduce new clinical considerations for oncology nurses and advanced practice providers ...

Welcome to Onc Nurse On Call, the new podcast from Oncology Nursing News, hosted by editors-in-chief Patricia Jakel, MN, RN, AOCN, and Stephanie Desrosiers, DNP, MSN, RN, AOCNS, BMTCN, delivering ...

The FDA has approved a monthly dosing schedule for subcutaneous amivantamab in NSCLC following the first 4 weeks of treatment ...

The FDA has approved Optune Pax, a wearable medical device that delivers Tumor Treating Fields (TTFields), for the treatment of adult patients with locally advanced pancreatic cancer (LA-PAC) ...

Emese Zsiros, MD, PhD, FACOG, discusses managing paclitaxel toxicity and the role of pembrolizumab maintenance in treating ...

In a clip from the latest Onc Nurse on Call episode, social worker Kelly Grosklags explains that emotions strengthen the connection between patient and clinician in oncology.

National projections estimate ~5800 new diagnoses and ~1720 deaths daily in 2026, with lung cancer expected to cause 124,990 deaths, exceeding colorectal plus pancreatic combined. Five-year relative ...

Deborah (Debi) A. Boyle MSN, RN, AOCNS, FAAN, is editor in chief of Oncology Nursing News®. She is a long tenured oncology clinical nurse specialist who has practiced in both Comprehensive Cancer ...

Cancer remains one of the most significant public health challenges globally, accounting for nearly 10 million deaths each year. 1 Still, only a handful of cancer types have recommended routine ...

A 375 mg/75 mL nelarabine vial now complements the 250 mg/50 mL formulation, aiming to streamline high-volume compounding and improve BSA-tailored dosing precision. Indication remains ...